Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 53.50

-1.3%

Jan 16 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (5869)	3/11/2002 4:49:34 PM
From: Biomaven	Read Replies (1) of 52153

tuck, That is a very interesting area. I don't believe we'll see animal-free testing for a long time, but every innovation helps. Aside from pure gene expression analysis, others are figuring ways to use living cells to analyze toxicity. For example, Harvard Biosciences (a trickle-type company) has something called Scantox which they suggest as an alternative to live animal testing: harvardapparatus.com Basically they use a bovine lens as a surrogate for live animal testing. You could probably use the Ciphergen protein chips as well - I think they might actually be a better bet than gene chips because they might pick up protein/tox interactions that a simple gene chip analysis might miss. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next